Ying-Qing Li

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center, University of South China

发表论文 2 篇 · 总被引 206 次 · h-index 2

代表论文

• Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial (2024 · The Lancet · 被引 181)
• The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma (2024 · Neuro-Oncology · 被引 13)